Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-798-5 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin irritation / corrosion
Administrative data
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From May 18, 2017 to June 23, 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Deviations:
- yes
- Remarks:
- Deviation was not considered to have affected the integrity or interpretation of the results
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- Reaction mass of mono- and di- hexadecyl phosphate esters, potassium salts and phosphoric acid
- Molecular formula:
- C16H34O4P1K1 (representative: mono- C16 PSE, K+)
- IUPAC Name:
- Reaction mass of mono- and di- hexadecyl phosphate esters, potassium salts and phosphoric acid
- Test material form:
- solid: particulate/powder
Constituent 1
In vitro test system
- Test system:
- human skin model
- Remarks:
- MatTek EpiDermTM tissue model EPI-200
- Cell type:
- other: Normal human-derived epidermal keratinocytes which have been cultured to form a multi-layered highly differentiated model of the human epidermis.
- Justification for test system used:
- Initially the predictive capacity of the modified EpiDerm™ Skin Irritation Test (SIT) test method, using MatTek EpiDermTM tissue model EPI-200, underwent full prospective validation from 2003-2007. The test method components of this method were used to define the essential test methods components of the original and updated ECVAM Performance Standards (PS). A modification of the original EpiDerm™ SIT was validated using the original ECVAM PS in 2008. In 2008, ESAC concluded that the Modified EpiDerm™ SIT has sufficient accuracy and reliability for prediction of R38 skin irritating and no-label (non-skin irritating) test substances.
- Vehicle:
- unchanged (no vehicle)
- Details on test system:
- Test system:
The reconstructed human epidermal model EpiDermTM (EPI-200-MatTek Corporation) consists of normal human-derived epidermal keratinocytes which have been cultured to form a multi-layered highly differentiated model of the human epidermis. It consists of organised basal, spinous and granular layers and a multi-layered stratum corneum containing intercellular lamellar lipid layers arranged in patterns analogous to those found in vivo.
Characterisation of the test system:
MatTek’s EpiDermTM model has been extensively characterised for multiple parameters including morphology, tissue viability, skin barrier function and sterility. QC results for the specific lot of models received (Lot# 25819) were checked in-house for MatTek acceptance ranges with the following outcome:
- Morphology - PASS
- Tissue viability - PASS
- Skin barrier function (ET50 value for 1 % Triton X-100) where ET50 is the time taken for 1 % Triton X-100 to reduce the viability of the skin model to 50 % relative to the negative control) - PASS
- Sterility testing showed no contamination during long term antibiotic and antimycotic free culture - PASS - Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- 25 mg after pre-wetting with 25 uL of DPBS
- Duration of treatment / exposure:
- 60 ± 1 minutes of treatment
- Duration of post-treatment incubation (if applicable):
- 42 ± 4 h
- Number of replicates:
- 3 replicates for the test substance, positive and negative control
Results and discussion
In vitro
Resultsopen allclose all
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- Test substance
- Value:
- ca. 93.5
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of irritation
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- Positive control
- Value:
- ca. 3.1
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- positive indication of irritation
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- Negative control
- Value:
- ca. 100
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of irritation
- Other effects / acceptance of results:
- - Prior to the study, the required compatibility checks (as per SOP L0029) confirmed that the test substance did not interfere with MTT and no water colouration was observed.
Any other information on results incl. tables
Results
Table 1: Viability measurements after 60 ±1 min of application and 42 ± 4 h post-incubation of test and reference substances and controls
Condition |
Tissue # |
Raw data |
Blank corrected data |
Mean OD |
% of Viability |
||
Aliquot 1 |
Aliquot 2 |
Aliquot 1 |
Aliquot 2 |
||||
NC |
Tissue 1 |
1.967 |
2.084 |
1.800 |
1.917 |
1.858 |
100.6 |
Tissue 2 |
2.095 |
2.182 |
1.928 |
2.015 |
1.971 |
106.8 |
|
Tissue 3 |
1.856 |
1.897 |
1.689 |
1.730 |
1.709 |
92.6 |
|
PC |
Tissue 1 |
0.225 |
0.2 |
0.058 |
0.033 |
0.045 |
2.4 |
Tissue 2 |
0.237 |
0.217 |
0.070 |
0.050 |
0.060 |
3.2 |
|
Tissue 3 |
0.24 |
0.229 |
0.073 |
0.062 |
0.067 |
3.6 |
|
TA2 |
Tissue 1 |
2.005 |
2.027 |
1.838 |
1.860 |
1.849 |
100.1 |
Tissue 2 |
2.008 |
1.821 |
1.841 |
1.654 |
1.747 |
94.6 |
|
Tissue 3 |
1.698 |
1.799 |
1.531 |
1.632 |
1.581 |
85.6 |
NC: negative control (DPBS), PC: Positive control (SDS 5%), TA2: Test substance.
Note: Rounded figures used.
Table 2: Mean and SD of cell viability measurements and of viability percentages after a 60 ±1 min application and 42 ± 4 h post-incubation
Name |
Code |
Mean of OD |
SD of OD |
Mean of viability (%) |
SD of viability (%) |
CV % |
Classification |
DPBS |
NC |
1.846 |
0.131 |
100.0 |
7.12 |
7.12 |
Non-Irritant |
SDS 5% |
PC |
0.057 |
0.011 |
3.1 |
0.61 |
19.51 |
Irritant |
Test substance |
TA2 |
1.726 |
0.135 |
93.5 |
7.31 |
7.83 |
Non-Irritant |
Prediction model of irritancy: test substances that reduce the viability to 50% or below are irritant (I), test substances with a percentage viability above 50% are considered to be non-irritant (NI).
Note: Rounded figures used.
Evaluation of the results
Results were checked against the following acceptance criteria:
|
Description |
Actual values |
PASS/FAIL |
Acceptance criterion 1 |
The mean OD570 of the negative control tissues is≥ 0.8 and ≤ 2.8
|
1.846 |
PASS |
Acceptance criterion 2 |
The mean of the positive control relative percentage viability must be ≤ 20% of the mean of the negative controls.
|
3.1% |
PASS |
Acceptance criterion 3 |
The standard deviation of OD values for triplicate skin models in each experimental condition must be < 18%
|
NC: 7.12% PC: 0.61% TA2: 7.31% |
PASS |
Acceptance criterion 4 |
The mean OD of the 6 wells containing extraction solvent alone (blanks) should be ≤ 0.1.
|
0.1673 |
FAIL* |
*All acceptance criteria were met with the exception of criterion 4:
Optical Density (OD) values obtained with blanks were higher than 0.1 (0.1673) causing a deviation from Acceptance Criteria 4. However, the spectrophotometer was fully validated and had passed all required tests. The OD values for blanks observed in this study are consistent with historical data using this spectrophotometer in the XCellR8 laboratory and meet our current internal acceptance criteria of blank OD values < 0.194 (mean XCellR8 historical data, based on blanks obtained during the last 66 studies), therefore this is not considered to be an issue in the interpretation of this study data.
This SOP and guideline deviation was not considered to have affected the integrity or interpretation of the results as no equivocal results were obtained.
Interpretation of Results following Prediction Model
- A test substance is considered to be an irritant (I) to skin in accordance with UN GHS Category 2 or EU R38 if the skin model viability after exposure and post-treatment incubation is ≤50%.
- A test substance may be considered as a non-irritant (NI) if the skin model viability after exposure and post-treatment incubation is >50%.
The
percentage of viability obtained with the
test substance was
93.5%, therefore it is considered as non-Irritant to the skin.
Applicant's summary and conclusion
- Interpretation of results:
- other: CLP
- Remarks:
- non-irritant based on CLP criteria
- Conclusions:
- Under the study conditions, the test substance was determined to be non-irritant to skin.
- Executive summary:
An in vitro study was conducted to determine the skin irritation potential of the test substance, 'mono- and di- C16 PSE, K+ and H3PO4' (purity: 100%), using Reconstructed Human Epidermis (RHE) method, according to OECD Guideline 439, in compliance with GLP. Three tissues of the human skin model EpiDermTM were treated with the test substance, positive or negative controls for 60 minutes (25 minutes at room temperature and 35 minutes at 37°C, 5 % CO2, 95 % RH) and 42 h post incubation period. Test was performed with 3 replicates for each type of treatment. Tissues were first pre-wetted with 25 μL DPBS (Sterile Dulbecco’s Phosphate Buffered Saline), subsequently 25 mg (nominal) of the neat test substance was applied. 30 μL of DPBS was used as negative control and 5% of sodium dodecyl sulphate (SDS) as positive control. Viability of the tissues was assessed in MTT test and compared to the negative control. The percentage of viability obtained with the test substance was 89.1%, which is well above the irritant limit of 50%. The study met all the validity criteria. Under the study conditions, the test substance was determined to be non-irritating to skin (XCellR8, 2017).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.